Halladay Benjamin sold ESPR
June 17, 2025 · Form 4 insider transaction
Halladay Benjamin sold 7,229 shares of Esperion Therapeutics, Inc. Common Stock at $1.15 per share, a transaction worth $8.3K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
7,229
Price
$1.15
Total value
$8.3K
InsiderHalladay Benjamin
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 17, 2025
Filing dateJune 18, 2025
Shares owned after474,473
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares were sold to satisfy tax obligation on vested shares of restricted stock units.